(Yicai) Feb. 5 -- China is taking countermeasures, including retaliatory tariffs, new export controls, and a dispute filing with the World Trade Organization, in response to US President Donald Trump's executive order imposing a 10 percent levy on imports from the Asian country.

China will impose additional tariffs on certain US products starting Feb. 10, including 15 percent on coal and liquefied natural gas and 10 percent on crude oil, agricultural machinery, large-displacement vehicles, and pickup trucks, the authorities said yesterday.

On the same day, China announced new export controls on five critical minerals: tungsten, tellurium, bismuth, molybdenum, and indium. The commerce ministry also added Calvin Klein's US owner PVH and California-based biotechnology firm Illumina to its unreliable entity list.

In addition, the ministry said China has filed a case against the US tariff measures under the WTO dispute settlement mechanism to defend its legitimate rights and interests.

The tariffs on Chinese imports seriously violate WTO rules and represent typical unilateralism and trade protectionism, a ministry spokesperson said. The US actions severely undermine the rules-based multilateral trading system, damage the foundation of China-US economic and trade cooperation, and disrupt global supply chains, the person added.

China firmly opposes these actions and urges the United States to immediately correct its wrongful practices, the official stressed.

In response to the 10 percent tariff the US imposed under the pretext of concerns over illegal street fentanyl, a Chinese Embassy spokesperson said that the Asian country has one of the world's strictest anti-drug policies.

At the request of the US, China announced in 2019 the official scheduling of all fentanyl-related substances, becoming the first country in the world to do so, and the pair have cooperated extensively in the area, the person pointed out, adding that the US should take an objective and rational approach to addressing its domestic fentanyl issues.

Editor: Martin Kadiev